NanoViricides Statistics
Total Valuation
NanoViricides has a market cap or net worth of $22.67 million. The enterprise value is $17.52 million.
Important Dates
The last earnings date was Tuesday, February 17, 2026, after market close.
| Earnings Date | Feb 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NanoViricides has 21.60 million shares outstanding. The number of shares has increased by 32.23% in one year.
| Current Share Class | 21.60M |
| Shares Outstanding | 21.60M |
| Shares Change (YoY) | +32.23% |
| Shares Change (QoQ) | +16.20% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 8.05% |
| Float | 19.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.05 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.43
| Current Ratio | 4.43 |
| Quick Ratio | 4.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -77.53% and return on invested capital (ROIC) is -48.90%.
| Return on Equity (ROE) | -77.53% |
| Return on Assets (ROA) | -44.02% |
| Return on Invested Capital (ROIC) | -48.90% |
| Return on Capital Employed (ROCE) | -75.82% |
| Weighted Average Cost of Capital (WACC) | 11.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.19M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.85% in the last 52 weeks. The beta is 1.32, so NanoViricides's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -19.85% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 1.38 |
| Relative Strength Index (RSI) | 51.59 |
| Average Volume (20 Days) | 255,127 |
Short Selling Information
The latest short interest is 844,114, so 3.91% of the outstanding shares have been sold short.
| Short Interest | 844,114 |
| Short Previous Month | 657,631 |
| Short % of Shares Out | 3.91% |
| Short % of Float | 4.30% |
| Short Ratio (days to cover) | 2.96 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.39M |
| Pretax Income | -8.32M |
| Net Income | -8.32M |
| EBITDA | -7.78M |
| EBIT | -8.39M |
| Earnings Per Share (EPS) | -$0.48 |
Full Income StatementBalance Sheet
The company has $5.15 million in cash and n/a in debt, with a net cash position of $5.15 million or $0.24 per share.
| Cash & Cash Equivalents | 5.15M |
| Total Debt | n/a |
| Net Cash | 5.15M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 11.07M |
| Book Value Per Share | 0.51 |
| Working Capital | 4.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.34 million and capital expenditures -$94,516, giving a free cash flow of -$7.43 million.
| Operating Cash Flow | -7.34M |
| Capital Expenditures | -94,516 |
| Free Cash Flow | -7.43M |
| FCF Per Share | -$0.34 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
